FDA Approved: XIFYRM — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved XIFYRM (meloxicam) under an original application by Azurity Pharmaceuticals, Inc., establishing a new branded meloxicam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• XIFYRM (meloxicam)

Snippet

ORIG AP for XIFYRM (MELOXICAM)